NURIX THERAPEUTICS, INC.

Profile

Company Names

NURIX THERAPEUTICS, INC.
NURIX, INC.

Addresses

1700 OWENS STREET, SUITE 205, SAN FRANCISCO, CA 94158

1700 OWENS STREET, SUITE 500, SAN FRANCISCO, CA 94158

Phone Numbers

(415) 660-5320
(415) 865-2057

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$144,660,106.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-03-09 
$120,249,972.00 
$120,249,972.00 
$0.00 
Equity 
4
2015-09-03 
$17,033,334.00 
$17,033,334.00 
$0.00 
Equity 
3
2013-12-18 
$2,075,000.00 
$25,150,000.00 
$23,075,000.00 
Equity 
2
2012-04-30 
$5,300,000.00 
$5,300,000.00 
$0.00 
Equity 
1
2012-04-07 
$1,800.00 
$1,800.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEON 
 
CHEN 
DIRECTOR
TIFFS TREATS HOLDINGS INC   |  PARTSCHANNEL INVESTORS, INC.   |  TIFF-S TREATS HOUSTON LTD.   |  TIFF-S TREATS ATX 2 LTD.   |  GENOCEA BIOSCIENCES, INC.   |  CRESCENDO BIOSCIENCE, INC.   |  TIFF-S TREATS HOLDINGS, INC.   |  E-SCAPE BIO, INC.   |  RFXCEL CORP   |  LOGICBIO THERAPEUTICS, INC.   |  FOG PHARMACEUTICALS, INC.   |  NATURAL PARTNERS, INC   |  NURIX THERAPEUTICS, INC.   |  TIFF-S TREATS RALEIGH LTD.   |  TIFF-S TREATS GP OKLAHOMA, LLC   |  TIFF-S TREATS OKLAHOMA LTD.   |  TIFF-S TREATS TAMPA, LTD.   |  TIFF-S TREATS DENVER LTD.   |  EIKON THERAPEUTICS, INC.   |  SERANOVA BIO, INC.   |  PLEXIUM, INC.
DAVID 
 
GOEDDEL 
DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
MARK 
 
GOLDSMITH 
DIRECTOR, EXECUTIVE OFFICER
IGENICA INC   |  NURIX, INC.   |  IGENICA BIOTHERAPEUTICS, INC
JULIA 
 
GREGORY 
DIRECTOR
CLINIPACE INC   |  ICONIC THERAPEUTICS INC   |  NURIX THERAPEUTICS, INC.   |  IMV INC.
LORI 
 
KUNKEL 
DIRECTOR
TOCAGEN INC   |  MAVERICK THERAPEUTICS INC.   |  NURIX THERAPEUTICS, INC.   |  ORIC PHARMACEUTICALS, INC.
TIMOTHY 
 
KUTZKEY 
EXECUTIVE OFFICER, DIRECTOR
NURIX, INC.
DAVID 
 
LACEY 
DIRECTOR
ATRECA, INC.   |  NURIX THERAPEUTICS, INC.
CHRISTINE 
 
RING 
EXECUTIVE OFFICER
NURIX THERAPEUTICS, INC.
ARTHUR 
 
SANDS 
EXECUTIVE OFFICER, DIRECTOR
NURIX THERAPEUTICS, INC.
ARTHUR 
T. 
SANDS 
EXECUTIVE OFFICER, DIRECTOR
LEXICON PHARMACEUTICALS, INC./DE   |  NURIX, INC.
KUTZKEY 
 
TIMOTHY 
EXECUTIVE OFFICER, DIRECTOR
NURIX, INC.
ROBERT 
 
TJIAN 
DIRECTOR
ESCIENT PHARMACEUTICALS INC   |  NEURONA THERAPEUTICS INC   |  NURIX THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS, INC
JEFF 
 
TONG 
DIRECTOR
NURIX THERAPEUTICS, INC.   |  MAREA THERAPEUTICS, INC.
HANS 
 
VAN HOUTE 
EXECUTIVE OFFICER
NURIX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-26
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-09 
2015-09-18
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-03 
2014-01-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-18 
2013-03-28
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-30 
2012-05-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-07 
2012-05-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#